Myovant Sciences Ltd Equity-NMS: MYOV

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$26.89
Open :	$26.88
Today's high :	$26.9
Today's low :	$26.88
52W low :	$7.67
52W high :	$27.03
1Y :	16.43%
5Y :	49.67%
Shares O/S :	97.24 M
Market cap :	2.61 B

What is the share price of Myovant Sciences Ltd today?

Myovant Sciences Ltd (MYOV) share price as of October 11, 2022, is $24.7564. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Myovant Sciences Ltd?

Yes, Indian Investors can invest in the Myovant Sciences Ltd (MYOV) Share by opening an international trading account with Angel One.

How can I purchase Myovant Sciences Ltd shares in India?

Purchasing Myovant Sciences Ltd (MYOV) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Myovant Sciences Ltd (MYOV) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Myovant Sciences Ltd?

Yes, you can purchase fractional shares of Myovant Sciences Ltd (MYOV) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Myovant Sciences Ltd?

The market capitalization of Myovant Sciences Ltd on February 5, 2023, is $2.37 B.

In which sector Myovant Sciences Ltd belongs?

Myovant Sciences Ltd operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Myovant Sciences Ltd stocks?

In order to invest in Myovant Sciences Ltd (MYOV) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Myovant Sciences Ltd is a biopharmaceutical company. The Company is focused on redefining care for women and for men through science, medicines and transformative advocacy. The Company’s two products include ORGOVYX (relugolix 120 mg), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer; and MYFEMBREE, a once-daily oral treatment for the management of heavy menstrual bleeding associated with uterine fibroids. The Company, through its subsidiary, Myovant Sciences GmbH develops supplemental New Drug Application for once-daily MYFEMBREE for the management of moderate to severe pain associated with endometriosis and being assessed for contraceptive efficacy in women ages 18-35 years who are at risk for pregnancy. It develops Relugolix for the treatment of men with advanced prostate cancer. The Company is also developing MVT-602, which has completed a Phase IIa study for the treatment of female infertility.